Recent news on the trial:

​

"Bionic Sight's BS01 Gene Therapy Receives RMAT Designation from the FDA"

GlobeNewswire, February 18, 2025

​

"Restoring Sight is Possible Now With Optogenetics": Bionic Sight's interim clinical trial results

Washington Post, April 23, 2024

​

Bionic Sight Reports Meaningful Vision Improvements for RP Patients Receiving Highest Dose of its Emerging Optogenetic Therapy

Foundation Fighting Blindness, April 21, 2023

​

Positive Interim Results in Bionic Sight's Optogenetic Gene Therapy Trial

Presentation at conference entitled, "Gene Therapy for Ophthalmic Disorders", Sept, 2021 

​

First Four Patients in Bionic Sight's Optogenetic Gene Therapy Trial Are Able to Detect Light and Motion

GlobeNewswire, March 30, 2021

​

For other related news, click here.

​

​